Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (19)
- Safety monitoring and information (12)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Legislation (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
Collection content
110 result(s) found, displaying 81 to 90
-
FormsSponsors can use this form to apply for an additional trade name for a registered prescription medicine, under section 23 of the Therapeutic Goods Act 1989.
-
Medicine shortage alertsSupply constraints will apply to Creon 25,000 unit and 35,000 unit capsules until 30 June 2026.
-
FormsThe Pre-submission Planning Form (PPF) provides the TGA with the necessary information on the scope and scale of application to arrange appropriate resourcing for the processing and evaluation of an application.
-
FormsApplication form to import, supply or export a therapeutic good that does not comply with standards.
-
FormsFind out how the free trade agreement affects your application to include a product on the Australian Register of Therapeutic Goods.
-
User guideFind out when you should use a literature-based submissions (LBS) for your application.
-
User guideUser guide on how to submit shortage/discontinuation notifications to the TGA
-
User guideThis user guide describes how to change sponsor details in the Product Information (PI) and labels for prescription medicines
-
User guideA user guide on how to change sponsor details in PI and labels.
-
FormsSponsors should note that the Bioequivalence Study Information Form (BSIF) has been amended